EBS Financial Facts

Selling, general and administrative: 31.56M
Contracts and grants: 29.65M
See Full Income Statement

Deferred revenue, current portion: 8.73M
Income tax receivable, net: 3.43M
See Full Balance Sheet

Emergent BioSolutions, Inc. (EBS) Earnings

  |   Expand Research on EBS
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +47.1% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +5.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/5/15 Q315 $0.83$0.55 +$0.28$164.9M$151.42M = Details
3/5/15 Q115 $0.75$0.69 +$0.06$148M$147M = Details
11/6/14 Q414 $0.67$0.52 +$0.15$138M$126.9M = Details
8/6/15 Q215 $0.36$0.18 +$0.18$126.1M$114.25M = Details
3/8/12 Q411 $0.78$0.72 +$0.06$107.95M$109.32M = Details
8/7/14 Q214 $0.13$0.32 -$0.19$110.3M$109.25M Details
3/10/11 Q410 $0.78$0.67 +$0.11$103.2M$102.03M = Details
3/7/13 Q412 $0.44$0.45 -$0.01$94.6M$95.09M = Details